Weekly News Recap #Phispers
FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development

FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development

This week’s Phispers brings you news on how artificial intelligence (AI) is taking centerstage in the world of pharmaceut...

Impressions : 2325

Merck buys Terns Pharma for US$ 6.7 bn to boost cancer portfolio; Novartis acquires Synnovation unit for up to US$ 3bn

Merck buys Terns Pharma for US$ 6.7 bn to boost cancer portfolio; Novartis acquires Synnovation unit for up to US$ 3bn

This week’s Phispers is packed with news of drug approvals and M&As. Merck is preparing for its future post-Keytruda pate...

Impressions : 1006

Lilly’s Zepbound becomes first FDA-approved therapy for sleep apnea; Novo wins nod for daily hemophilia shot

Lilly’s Zepbound becomes first FDA-approved therapy for sleep apnea; Novo wins nod for daily hemophilia shot

This week’s Phispers is a double bill with news from the last two weeks. Through much of December, the US Food and Drug A...

Impressions : 1460

Vertex’s non-opioid painkiller succeeds in late-stage trials, FDA finalizes CAR-T guidance

Vertex’s non-opioid painkiller succeeds in late-stage trials, FDA finalizes CAR-T guidance

In Phispers this week, there is news of an experimental non-opioid painkiller from Vertex Pharmaceuticals showing positive res...

Impressions : 1248

White House unveils plans to roll out jabs for 5 to 11 year olds; FDA authorizes Moderna, J&J boosters

This week, Phispers has more updates on Covid vaccines and boosters. Novavax’s Covid-19 vaccine program may have hit a br...

Impressions : 1743

FDA highlights data-integrity concerns at Pfizer’s India unit; FDA requests removal of all ranitidine products

This week, N-nitrosodimethylamine (NDMA) is back in news as the FDA requests manufacturers to withdraw ranitidine from the mark...

Impressions : 3646

US Senator seeks “unannounced” FDA inspections; Nektar reports manufacturing issues with lead project

This week in Phispers, we bring you news about Nektar Therapeutics which disclosed declining efficacy of its lead project due t...

Impressions : 2688

FDA releases GDUFA II fee for FY20; Teva to recover settlement charge from execs

This week, the USFDA released its GDUFA II user fee for fiscal 2020. Unlike last year, when the fees were hiked significantly...

Impressions : 1680